BACKGROUND:Metastatic breast cancer (MBC) remains a devastating and incurable disease. Over the past decade. the implementation of clinical trials both with and without molecular targeted therapeutics has impacted the daily clinical treatment of patients with MBC. In this study. https://www.mariameetsanna.com/product-category/professional-kit/